Establishment of a Mouse Xenograft Model for Mycosis Fungoides
Overview
Authors
Affiliations
Mycosis fungoides (MF) is the most frequent variant of cutaneous T-cell lymphomas (CTCLs). MF primarily involves the skin initially with patches and plaques. In later stages, cutaneous tumors develop and tumor cells may spread to lymph nodes and finally to visceral sites. Here, we describe an animal model for MF in immune-deficient nude mice, using the CTCL cell line MyLa. Subcutaneous transplantation of MyLa cells leads to the formation of cutaneous tumors in 80% of the mice (50/60 total). Spread of tumor cells to visceral sites was detected by immunohistochemistry and polymerase chain reaction (PCR)-based detection of specific T-cell receptor-gamma rearrangement. MyLa cells were found circulating in the blood, lymph nodes, and in blood vessels of heart, kidney, lung, and liver. In lung and liver tissue, tumor cells presented perivascular invasion, but no large secondary tumors developed. The nude mouse model described here will be a valuable test system for new therapeutic approaches for the treatment of MF and opens the unique opportunity to study the disease in vivo.
"Next top" mouse models advancing CTCL research.
Luo Y, de Gruijl F, Vermeer M, Tensen C Front Cell Dev Biol. 2024; 12:1372881.
PMID: 38665428 PMC: 11044687. DOI: 10.3389/fcell.2024.1372881.
Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
Gao J, Ren S, Choonoo G, Chen G, Frleta D, Zhong J Dis Model Mech. 2023; 16(10).
PMID: 37718909 PMC: 10581384. DOI: 10.1242/dmm.050190.
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
Sorger H, Dey S, Vieyra-Garcia P, Poloske D, Teufelberger A, de Araujo E EMBO Mol Med. 2022; 14(12):e15200.
PMID: 36341492 PMC: 9727928. DOI: 10.15252/emmm.202115200.
Habault J, Thonnart N, Ram-Wolff C, Bagot M, Bensussan A, Poyet J Cells. 2022; 11(19).
PMID: 36230895 PMC: 9564267. DOI: 10.3390/cells11192933.
Karagianni F, Piperi C, Casar B, de la Fuente-Vivas D, Garcia-Gomez R, Lampadaki K Cancers (Basel). 2022; 14(4).
PMID: 35205818 PMC: 8870185. DOI: 10.3390/cancers14041070.